SEARCH

SEARCH BY CITATION

References

  • 1
    Scottish Perinatal and Infant Mortality and Morbidity Report 2000. Information and Statistics Division (ISD): Edinburgh, UK. http://www.show.scot.nhs.uk/isdonline/sexual_health/SBID/All_text.htm [Accessed 23 June 2003].
  • 2
    Goldenberg RL, Iams JD, Miodovnik M, Van Dorsten JP, Thurnau G, Bottoms S, Mercer BM, Meis PJ, Moawad AH, Das A, Caritis SN, McNellis D. The preterm prediction study: risk factors in twin gestations. Am J Obstet Gynecol 1996; 175: 10471053.
  • 3
    Wennerholm U-B, Holm B, Mattsby-Baltzer I, Neilsen T, Platz-Christensen J, Sundell G, Hosseini N, Hagberg H. Fetal fibronectin, endotoxin, bacterial vaginosis and cervical length as predictors of preterm birth and neonatal morbidity in twin pregnancies. Br J Obstet Gynaecol 1997; 104: 13981404.
  • 4
    Imseis HM, Albert TA, Iams JD. Identifying twin gestations at low risk for preterm birth with a transvaginal ultrasonographic cervical measurement at 24 to 26 weeks' gestation. Am J Obstet Gynecol 1997; 177: 11491155.
  • 5
    Souka AP, Heath V, Flint S, Sevastopoulou I, Nicolaides KH. Cervical length at 23 weeks in twins in predicting spontaneous preterm delivery. Obstet Gynecol 1999; 94: 450454.
  • 6
    Guzman ER, Walters C, O'Reilly-Green C, Kinzler WL, Waldron R, Nigam J, Vintzileos AM. Use of cervical ultrasonography in the prediction of spontaneous preterm birth in twin gestations. Am J Obstet Gynecol 2000; 183: 11031107.
  • 7
    Skentou C, Souka AP, To MS, Liao AW, Nicolaides KH. Prediction of preterm delivery in twins by cervical assessment at 23 weeks. Ultrasound Obstet Gynecol 2001; 17: 710.
  • 8
    Vayssiere C, Favre R, Audibert F, Chauvet MP, Gaucherand P, Tardif D, Grangé G, Novoa A, Descamps P, Perdu M, Andrinin E, Janse-Marec J, Maillard F, Nisand I, for the Research Group in Obstetrics and Gynecology (GROG). Cervical length and funnelling at 22 and 27 weeks to predict spontaneous birth before 32 weeks in twin pregnancies: a French prospective multicenter study. Am J Obstet Gynecol 2002; 187: 15961604.
  • 9
    Sadovsky Y, Freidman SA. Fetal fibronectin and preterm labor. N Engl J Med 1992; 326: 709.
  • 10
    Shimoya K, Hashimoto K, Shimizu T, Saji F, Marata Y. Effect of sexual intercourse on fetal fibronectin concentration in cervicovaginal secretions. Am J Obstet Gynecol 1998; 179: 255256.
  • 11
    Jaeschke R, Guyatt G, Sackett DL. Users' guide to the medical literature III. How to use an article about a diagnostic test. JAMA 1994; 271: 389391.
  • 12
    Guzman ER, Mellon C, Vintzileos AM, Ananth CV, Walters C, Gipson K. Longitudinal assessment of endocervical canal length between 15 and 24 weeks' gestation in women at risk for pregnancy loss or preterm birth. Obstet Gynecol 1998; 92: 3137.
  • 13
    Ong S, Smith A, Smith N, Campbell D, Wilson A. Cervical length assessment in twin pregnancies using transvaginal ultrasound. Acta Obstet Gynecol Scand 2000; 79: 851853.
  • 14
    Sender IPM, Owen P. Comparison of cervical assessment, fetal fibronectin and fetal breathing in the diagnosis of preterm labour. Clin Exp Obstet Gynecol 1996; 23: 59.
  • 15
    Chein PFW, Khan KS, Ogston S, Owen P. The diagnostic accuracy of cervico-vaginal fetal fibronectin in predicting preterm delivery: an overview. Br J Obstet Gynaecol 1997; 104: 436444.
  • 16
    Honest H, Bachmann LM, Gupta JK, Kleijnen J, Khan KS. Accuracy of cervicovaginal fetal fibronectin test in predicting risk of spontaneous preterm birth: systematic review. BMJ 2002; 325: 301304.
  • 17
    Crowley P. Prophylactic corticosteroids for preterm birth. Cochrane Database Syst Rev 2000; 2: CD000065.
  • 18
    Goldenberg RL, Wright LL. Repeated courses of antenatal corticosteroids. Obstet Gynecol 2001; 97: 316317.
  • 19
    Meis PJ, Klebanoff M, Thom E, Dombrowski MP, Sibai B, Moawad AH, Spong CY, Hauth JC, Miodovnik M, Varner MW, Leveno KJ, Caritis SN, Iams JD, Wapner RJ, Conway D, O'Sullivan MJ, Carpenter M, Mercer B, Ramin SM, Thorp JM, Peaceman AM. National Institute of Child Health and Human Development Maternal–Fetal Medicine Units Network. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. N Engl J Med 2003; 348: 23792385.
  • 20
    da Fonsceca EB, Bittar RE, Carvalho MHB, Zugaib M. Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomised placebo-controlled double-blind study. Am J Obstet Gynecol 2003; 188: 419424.
  • 21
    Goldenberg RL, Iams JD, Mercer BM, Meis PJ, Moawad A, Das A, Miodovnik M, VanDorsten PJ, Caritis SN, Thurnau G, Dombrowski MP. The Preterm Prediction Study: towards a multiple-marker test for spontaneous preterm birth. Am J Obstet Gynecol 2001; 185: 643651.